Roxicet Articles
Opana growth drives Endo's profit up 15%
16 March 2009
Illegal California pharmacy faces charges
2 June 2008
Endo Pharma sees 2nd-qtr profits slump
26 July 2004
Endo net sales surge 49% in 2003
23 February 2004
Watson gets FDA OK for generic Percocet
15 September 2003
Showing 1-5 of 5 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
